8-Hydroxy Moxifloxacin Hydrobromide(1292904-74-5)
- Name: 8-Hydroxy Moxifloxacin Hydrobromide
- Synonyms:8-Hydroxy Moxifloxacin Hydrobromide;1292904-74-5;3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-hydroxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-, hydrobromide (1:1), rel-;7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-hydroxy-4-oxoquinoline-3-carboxylic acid;hydrobromide;K8RL9S4AUD;1-Cyclopropyl-6-fluoro-1,4-dihydro-8-hydroxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid Hydrobromide;CS-0164472;A1-01729;8-Hydroxy moxifloxacin hydrobromide, (4aR,7aR)-rel-;1-Cyclopropyl-6-fluoro-1,4-dihydro-8-hydroxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid Hydrobromide? (Moxifloxacin Impurity pound(c);3-Quinolinecarboxylicacid,1-cyclopropyl-6-fluoro-1,4-dihydro-8-hydroxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-,hydrobromide(1:1),rel-;rel-1-Cyclopropyl-6-fluoro-8-hydroxy-7-((4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrobromide
- Molecular Formula:C20H23BrFN3O4
- Molecular Weight:468.3
- CAS Registry Number:1292904-74-5
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1292904-74-5 99% up by HPLC 8-Hydroxy Moxifloxacin Hydrobromide
Assay:99% up by HPLC Application:API
Min. Order:0
Supplier:Sinoway Industrial Co., Ltd. [
China (Mainland)] CAS No.1292904-74-5 Moxifloxacin Impurity E
Assay:> 95% Appearance:Solid powder Package:25 mg Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 1233025-96-1/2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-6-methoxy-1,2,3,4-tetrahydroisoquinoline-4-carboxylic acid
- 1260615-94-8/Fmoc-2,6-Dichloro-L-Phenylalanine
- 1270294-57-9/Cbz-2,6-Dimethyl-L-Phenylalanine
- 1373232-79-1/1-(4-Bromo-3-methoxyphenyl)cyclopropane-1-carboxylic acid
- 1352414-66-4/4-Methyl-2-(4-methylpiperidin-1-yl)-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)pyridine
- 1248360-64-6/2-(2,4-Difluorophenyl)-1,1,1-trifluoropropan-2-ol
- 1337881-15-8/3-Hydrazinylpropanamide hydrochloride
- 1260616-34-9/(R)-Tert-butyl 2-(tert-butoxycarbonylamino)-5-oxo-5-phenylpentanoate
- 1352414-67-5/4-Methyl-2-(4-methyl-1h-pyrazol-1-yl)-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)pyridine
- 1270295-08-3/Fmoc-2,3-Dimethyl-L-Phenylalanine
- 1337881-24-9/(5-Bromo-2-chloropyridin-3-yl)methanamine dihydrochloride
- 1373232-84-8/3-(3-Chlorophenyl)-5-methoxypyridine
- 1352414-68-6/n-Butyl-n,4-dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine
- 1186112-44-6/6-(3-Ethylureido)-4-(4-(pyridin-2-yl)thiazol-2-yl)pyridin-3-ylboronic acid
- 1248437-98-0/1-(5-Fluoropyridin-3-ylsulfonyl)pyrrolidin-3-amine
- 1260616-95-2/CID 129627272
- 1352414-69-7/n-(4-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)morpholin-4-amine
- 1355992-59-4/3'',4'',5'',6''-Tetrakis(4'-amino[1,1'-biphenyl]-4-yl)-[1,1':4',1'':2'',1''':4''',1''''-Quinquephenyl]-4,4''''-diamine
- 1186112-85-5/6-(3-Propylureido)-4-(4-(trifluoromethyl)thiazol-2-yl)pyridin-3-ylboronic acid
- 1292904-74-5/8-Hydroxy Moxifloxacin Hydrobromide
- 1352414-70-0/n-(4-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)benzenesulfonamide
- 1337881-43-2/2-(2,6-Dichlorophenyl)-2,3-dihydropyrrolo[3,4-c]pyridin-1-one
- 1356010-93-9/1-((2R)-2-Amino-2-cyclohexylacetyl)-N-(4'-cyanobenzyl)-2-L-azetidinecarboxamide
- 1186113-72-3/1-Ethyl-3-(4-(5-phenyl-1,3,4-oxadiazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)urea
- 1292905-33-9/3-((1R)-3-Hydroxy-1-phenyl-propyl)-4-hydroxy-benzoic acid methyl ester
- 1270295-34-5/Fmoc-3,5-Dimethyl-L-Phenylalanine
- 1337881-66-9/4-(2-Aminoethyl)-2-fluoro-N,N-dimethylbenzenamine dihydrochloride
- 1356010-95-1/(2S,3R,4E)-2-Amino-3-hydroxy-tetradecenoic Acid Ethyl Ester
- 1186113-73-4/Methyl 2-(3-ethylureido)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isonicotinate
- 1270295-36-7/Cbz-2,3-Dichloro-D-Phenylalanine